Renal Sympathetic Denervation in Mild Refractory Hypertension
Primary Purpose
Refractory Hypertension
Status
Completed
Phase
Phase 4
Locations
Germany
Study Type
Interventional
Intervention
Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA)
Sham procedure
Sponsored by

About this trial
This is an interventional treatment trial for Refractory Hypertension
Eligibility Criteria
Inclusion Criteria:
- Refractory hypertension: 3 or more antihypertensive agents of different classes (including a diuretic) at optimal dosage without change in the 4 weeks preceding randomization
- Systolic blood pressure of 135-149 and/or diastolic blood pressure of 90-94 mmHg (ABPM mean daytime values)
- No change in blood pressure medication within 6 months after randomization
- Age 18 to 75 years
- Informed consent
Exclusion Criteria:
- Blood pressure outside range mentioned above
- Renal, aortic or pelvic anatomy unsuited for renal sympathetic denervation
- Estimated glomerular filtration rate <45 mL/min/1.73 m² (modification of diet in renal disease formula)
- Unstable angina pectoris
- Myocardial infarction within 6 months prior to randomization
- Planned surgery or cardiovascular intervention within 6 months after randomization
- Severe heart valve disease
- Severe comorbidities with limited life expectancy
- Pregnancy
- Participation in another trial
Sites / Locations
- University of Leipzig Heart Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
Renal sympathetic denervation
Sham procedure
Arm Description
Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA)
Sham procedure mimicking the renal sympathetic denervation procedure in the experimental arm
Outcomes
Primary Outcome Measures
Change in systolic blood pressure (ABPM mean value)
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01656096
Brief Title
Renal Sympathetic Denervation in Mild Refractory Hypertension
Official Title
Renal Sympathetic Denervation in Patients With Mild Refractory Hypertension
Study Type
Interventional
2. Study Status
Record Verification Date
October 2016
Overall Recruitment Status
Completed
Study Start Date
July 2012 (undefined)
Primary Completion Date
July 2014 (Actual)
Study Completion Date
July 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Leipzig
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to examine the benefit of renal sympathetic denervation in patients with mild refractory hypertension
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Refractory Hypertension
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
71 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Renal sympathetic denervation
Arm Type
Experimental
Arm Description
Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA)
Arm Title
Sham procedure
Arm Type
Sham Comparator
Arm Description
Sham procedure mimicking the renal sympathetic denervation procedure in the experimental arm
Intervention Type
Device
Intervention Name(s)
Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA)
Intervention Type
Other
Intervention Name(s)
Sham procedure
Primary Outcome Measure Information:
Title
Change in systolic blood pressure (ABPM mean value)
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Refractory hypertension: 3 or more antihypertensive agents of different classes (including a diuretic) at optimal dosage without change in the 4 weeks preceding randomization
Systolic blood pressure of 135-149 and/or diastolic blood pressure of 90-94 mmHg (ABPM mean daytime values)
No change in blood pressure medication within 6 months after randomization
Age 18 to 75 years
Informed consent
Exclusion Criteria:
Blood pressure outside range mentioned above
Renal, aortic or pelvic anatomy unsuited for renal sympathetic denervation
Estimated glomerular filtration rate <45 mL/min/1.73 m² (modification of diet in renal disease formula)
Unstable angina pectoris
Myocardial infarction within 6 months prior to randomization
Planned surgery or cardiovascular intervention within 6 months after randomization
Severe heart valve disease
Severe comorbidities with limited life expectancy
Pregnancy
Participation in another trial
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steffen Desch, MD
Organizational Affiliation
Heart Center Leipzig - University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Leipzig Heart Center
City
Leipzig
ZIP/Postal Code
04289
Country
Germany
12. IPD Sharing Statement
Citations:
PubMed Identifier
25824248
Citation
Desch S, Okon T, Heinemann D, Kulle K, Rohnert K, Sonnabend M, Petzold M, Muller U, Schuler G, Eitel I, Thiele H, Lurz P. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension. Hypertension. 2015 Jun;65(6):1202-8. doi: 10.1161/HYPERTENSIONAHA.115.05283. Epub 2015 Mar 30.
Results Reference
derived
Links:
URL
http://www.ncbi.nlm.nih.gov/pubmed/25824248
Description
Publication of study
Learn more about this trial
Renal Sympathetic Denervation in Mild Refractory Hypertension
We'll reach out to this number within 24 hrs